interferoninduc
transmembran
ifitm
protein
famili
small
transmembran
protein
mediat
antivir
activ
type
ii
interferon
ifitmmedi
restrict
specif
particular
viru
famili
influenza
virus
iav
ebola
viru
ebov
marburg
viru
marv
sar
coronaviru
sarscov
dengu
viru
west
nile
viru
effici
restrict
one
ifitm
famili
protein
convers
ifitm
protein
restrict
murin
leukemia
viru
mlv
rang
alphavirus
arenavirus
includ
machupo
viru
macv
lassa
viru
lasv
lymphocyt
choriomening
viru
lcmv
vesicular
stomat
viru
ineffici
restrict
two
group
report
cell
linespecif
restrict
report
differ
cell
line
show
effici
restrict
restrict
activ
nonenvelop
virus
report
date
mechan
action
ifitmmedi
restrict
yet
determin
multipl
line
evid
indic
restrict
occur
virion
endocytosi
prior
membran
fusion
ifitm
protein
prevent
infect
retrovirus
pseudotyp
entri
protein
ifitmrestrict
virus
pseudotyp
entri
protein
unrestrict
virus
entri
assay
use
virion
contain
blamvpr
fusion
protein
likewis
reveal
ifitm
protein
prevent
transfer
blamvpr
cytosol
target
cell
previous
show
fluoresc
microscopi
label
iav
virion
intern
normal
traffic
acidifi
endocyt
compart
despit
ifitm
express
conclus
confirm
extend
feeli
et
al
use
rigor
set
imag
studi
demonstr
fluoresc
situ
hybrid
ifitm
protein
caus
sequestr
accumul
iav
genet
materi
late
endocyticlysosom
compart
ifitm
protein
also
local
late
endosomeslysosom
demonstr
coloc
moreov
ifitm
protein
overexpress
cell
line
interferon
treatment
result
enlarg
organel
final
recent
report
show
endosom
interferontr
ifitm
knockout
cell
ineffici
acidifi
suggest
physic
associ
subunit
vacuolar
atpas
complex
mediat
effect
appear
therefor
ifitm
protein
alter
properti
late
endosom
lysosom
render
organel
inhospit
viral
fusion
model
support
pattern
ifitmmedi
restrict
except
restrict
virus
gener
fuse
late
endocyt
pathway
wherea
unrestrict
virus
fuse
plasma
membran
earli
endocyt
compart
evid
restrict
depend
site
viral
fusion
come
investig
sarscov
sarscov
requir
lysosom
cathepsin
activ
entri
protein
fuse
lysosom
membran
treat
receptorbound
virion
trypsin
howev
remov
cathepsin
depend
induc
fusion
plasma
membran
bypass
ifitmmedi
entri
restrict
vertebr
two
ifitm
gene
human
ifitm
famili
compos
four
function
gene
murin
locat
chromosom
clear
ortholog
human
counterpart
mice
possess
two
addit
loci
also
locat
chromosom
retrogen
chromosom
protein
express
gene
restrict
influenza
viru
iav
filoviru
flaviviru
sar
coronaviru
entri
vitro
vari
effici
express
limit
bone
role
yet
clear
two
strain
knockout
mice
use
follow
experi
ifitmdel
mice
lack
mice
lack
alon
aim
present
studi
determin
vivo
contribut
ifitm
protein
innat
immun
control
iav
show
alon
make
signific
contribut
control
influenza
mice
provid
insight
express
regul
determin
vivo
relev
ifitm
protein
challeng
cohort
ifitmdel
wild
type
heterozyg
male
mice
intranas
dose
either
pfu
influenza
accord
institut
polici
mice
consid
moribund
euthan
upon
loss
initi
bodi
weight
defin
averag
preinocul
weight
challeng
dose
knockout
mice
exhibit
significantli
acceler
diseas
progress
mortal
compar
wild
type
control
figur
heterozygot
intermedi
phenotyp
modest
insignific
differ
observ
mean
surviv
time
knockout
mice
receiv
challeng
dose
mice
receiv
pfu
surviv
day
longer
pfu
challeng
dose
two
five
wild
type
anim
surviv
acut
infect
diseas
remain
uniformli
lethal
knockout
mice
weight
loss
day
significantli
increas
ifitmdel
heterozyg
anim
compar
wild
type
control
figur
plot
bodi
weight
figur
weight
loss
wild
type
anim
receiv
pfu
challeng
follow
trend
report
investig
price
et
al
found
mice
gener
maintain
bodi
weight
day
postinfect
underw
rapid
period
weight
loss
continu
day
rapid
clinic
progress
begin
day
coincid
onset
cellular
humor
immun
recoveri
day
correspond
clearanc
viru
contrast
wild
type
anim
ifitmdel
mice
began
steep
declin
weight
begin
day
consist
failur
innat
control
earli
infect
variabl
rate
diseas
progress
knockout
mice
also
far
lower
wild
type
heterozyg
anim
figur
result
demonstr
ifitm
protein
mediat
innat
immun
influenza
viru
acut
infect
effect
delet
power
enough
overwhelm
sourc
experiment
variat
intermedi
phenotyp
heterozyg
anim
show
gene
dosag
import
ifitm
proteinmedi
viral
restrict
requir
high
gene
dosag
may
also
explain
duplic
ifitm
allel
observ
multipl
speci
viral
load
measur
separ
cohort
mice
euthan
three
day
infect
period
bodi
weight
wild
type
ifitmdel
anim
diverg
figur
weight
loss
trend
cohort
anim
similar
previou
cohort
figur
viral
load
assess
realtim
rtpcr
lung
rna
higher
averag
p
ifitmdel
mice
compar
wild
type
control
figur
differ
splenic
viral
load
figur
similarli
increas
p
although
rel
differ
splenic
viral
load
high
iav
genom
copi
number
spleen
order
time
lower
lung
figur
genom
express
spleen
wild
type
anim
bare
detect
threshold
assay
similarli
identifi
splenic
lesion
lesion
beyond
lung
trachea
nasal
passag
consist
depend
hemagglutinin
respiratori
proteas
cleavag
activ
therefor
specul
increas
splenic
viral
load
knockout
mice
result
robust
infect
lung
subsequ
leakag
viru
viral
debri
peripheri
previous
report
murin
embryon
fibroblast
mef
deriv
ifitmdel
knockout
mice
highli
suscept
iav
baselin
interferoninduc
ifitm
protein
express
contribut
iav
resist
wild
type
mef
express
alon
suffici
restor
iav
entri
restrict
knockout
fibroblast
shown
overexpress
murin
ifitm
protein
human
cell
line
confer
level
iav
restrict
effect
poss
compar
littl
activ
confirm
observ
context
ifitmdel
mef
figur
murin
demonstr
potent
iav
restrict
activ
regardless
ha
type
like
part
due
higher
steadyst
express
level
figur
although
effect
restrict
iav
vitro
human
murin
ifitm
protein
restrict
iav
extent
overexpress
determin
specif
vivo
contribut
perform
addit
intranas
challeng
wild
type
ifitmdel
knockout
mice
pfu
mortal
weight
loss
trend
ifitmdel
wild
type
anim
similar
figur
surviv
time
knockout
mice
significantli
differ
ifitmdel
knockout
mice
p
weight
loss
curv
two
genotyp
superimpos
figur
b
ifitmdel
mice
heterozygot
knockout
mice
exhibit
intermedi
phenotyp
therefor
conclud
among
ifitm
protein
make
substanti
contribut
resist
vivo
promot
sensit
interferon
signal
reason
jakstatmedi
cytokin
might
likewis
induc
express
test
abil
type
iii
interferon
acut
phase
cytokin
oncostatin
osm
cytokin
releas
activ
dendrit
cell
synerg
type
interferon
upregul
express
latter
two
molecul
belong
divers
famili
cytokin
signal
hetero
multimer
receptor
activ
jakstat
pathway
via
common
subunit
consist
previou
studi
type
type
ii
interferon
induc
express
nih
murin
fibroblast
murin
macrophag
cell
line
ineffect
like
due
lack
appropri
receptor
cell
howev
oncostatin
osm
induc
strong
express
potent
induc
express
cell
figur
abil
two
cytokin
modul
express
correl
surfac
express
cognat
receptor
figur
due
increas
express
type
ii
interferon
figur
data
rais
possibl
cytokin
lif
could
modul
basal
induc
express
cell
bear
appropri
receptor
furthermor
indic
greater
specif
complex
regul
express
possibl
interferonstimul
gene
previou
studi
impli
human
interferonstimul
gene
murin
shown
interferoninduc
regul
murin
ifitm
particularli
mousespecif
famili
member
studi
therefor
assay
respons
murin
ifitm
promot
type
type
ii
interferon
figur
observ
murin
ifitm
gene
alon
interferoninduc
promot
figur
also
suggest
least
tissu
cultur
condit
ifitm
promot
may
constitut
activ
perhap
contribut
intrins
antivir
state
valid
result
promot
assay
analyz
cytokinemedi
upregul
murin
transcript
qrtpcr
consist
promot
studi
contrast
behavior
human
ortholog
murin
unrespons
type
type
ii
interferon
transcript
level
significantli
upregul
nih
cell
similarli
induc
osm
cell
raw
cell
consist
western
blot
promot
data
figur
also
appear
respond
osm
stimul
although
increas
statist
signific
data
figur
show
potent
iav
restrict
factor
murin
ifitm
protein
express
alon
effici
induc
interferon
determin
condit
express
vivo
perform
comprehens
immunohistochem
stain
lung
infect
uninfect
wild
type
mice
determin
baselin
influenzainduc
pattern
express
contrari
expect
constitut
express
seen
mani
lung
tissu
mark
induct
seen
respiratori
epithelium
lower
airway
figur
b
c
pattern
distribut
similar
remain
lung
tissu
iavinfect
uninfect
mice
constitut
express
observ
respiratori
epitheli
cell
upper
airway
figur
e
f
viscer
pleura
figur
h
leukocyt
figur
k
l
suggest
may
provid
protect
influenza
prior
interferon
acutephas
respons
immunostain
knockout
mice
observ
confirm
specif
antibodi
figur
also
local
express
specif
influenza
viru
target
cell
alveolar
type
ii
pneumocyt
ciliat
respiratori
epitheli
cell
immunofluoresc
confoc
microscopi
type
ii
pneumocyt
identifi
dclamp
express
marker
type
ii
pneumocytespecif
lysosomerel
organel
express
dclamp
posit
cell
also
coloc
dclamp
consist
previou
vitro
report
local
endosomallysosom
membran
figur
contrast
ciliat
respiratori
epithelium
show
intens
label
apic
cytoplasm
plasma
membran
rather
punctat
intracytoplasm
distribut
typic
lysosom
demonstr
lysosom
marker
figur
whether
function
differ
context
cell
apic
local
end
result
endolysosom
exocytosi
unknown
manuscript
review
everitt
et
al
publish
data
show
knockout
mice
suscept
infect
influenza
viru
wild
type
control
also
identifi
character
polymorph
human
associ
reduc
restrict
activ
found
increas
preval
mutant
allel
patient
hospit
influenza
data
support
extend
core
conclus
mous
studi
show
mice
lack
entir
ifitm
locu
exhibit
nearli
ident
diseas
cours
lack
alon
respect
heterozygot
litterm
exhibit
phenotyp
intermedi
knockout
wild
type
mice
morev
express
key
iav
target
cell
lung
among
murin
ifitm
uniqu
induc
type
ii
interferon
collect
data
make
clear
primari
role
control
influenza
viru
mice
also
show
mani
tissu
express
basal
level
protein
least
two
cytokin
osm
induc
express
even
absenc
interferon
respons
result
suggest
greater
complex
vivo
regul
wellcharacter
interferonstimul
gene
well
note
express
cell
popul
major
iav
target
macrophag
endotheli
cell
impli
delet
like
enhanc
suscept
infect
monocytetrop
flavivirus
macrophag
endotheliotrop
filovirus
result
may
also
implic
treatment
viral
infect
fact
express
induc
cytokin
may
allow
modul
express
target
less
pleiotrop
way
agon
antagon
cell
typespecif
heterodimer
receptor
gener
find
suggest
pharmacolog
induct
human
express
emul
activ
could
provid
broadspectrum
therapeut
approach
treatment
rang
human
pathogen
virus
studi
carri
strict
accord
recommend
guid
care
use
laboratori
anim
nation
institut
health
studi
approv
institut
anim
care
use
committe
harvard
medic
school
protocol
number
human
influenza
viru
propag
chicken
egg
sucros
gradient
purifi
allanto
fluid
obtain
charl
river
laboratori
aliquot
frozen
titer
determin
standard
plaqu
assay
madindarbi
canin
kidney
cell
heterozyg
ifitmdel
mice
background
strain
gener
provid
dr
david
adam
wellcom
trust
sanger
institut
cambridg
unit
kingdom
anim
hous
specif
pathogenfre
condit
prior
infect
mice
week
old
except
three
litterm
one
genotyp
use
figur
mice
anesthet
intraperiton
inject
cocktail
ketamin
mg
per
g
bodi
weight
xylazin
mg
per
g
bodi
weight
normal
salin
anesthet
mice
inocul
intranas
influenza
viru
dilut
phosphatebuff
salin
divid
evenli
nostril
administ
cours
one
two
minut
anim
weigh
daili
per
institut
requir
euthan
upon
loss
initi
bodi
weight
deem
moribund
base
clinic
sign
procedur
perform
approv
harvard
univers
institut
anim
care
use
committe
lung
spleen
harvest
rapidli
frozen
store
prior
rna
isol
tissu
thaw
rnalat
transfer
ml
lung
ml
spleen
rnaasefre
water
mechan
homogen
qiagen
tissueruptor
rna
extract
perform
mean
qiagen
rneasi
tissu
kit
qiashredd
column
qiagen
viral
load
determin
realtim
taqman
rtpcr
influenza
viral
primer
probe
sequenc
adapt
use
iav
protocol
develop
center
diseas
control
sequenc
caa
tcc
tgt
cac
ctc
tga
forward
primer
gca
ttt
tgg
aca
aag
cgt
revers
primer
agt
cct
cgc
tca
ctg
ggc
probe
report
quencher
dye
fam
ibfq
respect
addit
intern
zen
quencher
integr
dna
technolog
similarli
label
gapdh
primer
probe
sequenc
gag
tca
tac
tgg
aac
atg
forward
primer
ggt
gaa
ggt
cgg
tgt
revers
primer
aaa
tgg
cag
ccc
tgg
probe
integr
dna
technolog
reaction
contain
ng
rna
pmol
primer
pmol
probe
prepar
use
superscript
iii
onestep
rtpcr
system
platinum
taq
dna
polymeras
rox
invitrogen
cycl
condit
min
revers
transcript
min
denatur
cycl
second
dentatur
sec
anneal
extens
fluoresc
acquisit
cycl
fluoresc
detect
perform
abi
prism
thermal
cycler
appli
biosystem
entri
assay
perform
murin
embryon
fibroblast
mef
deriv
ifitmdel
knockout
mice
cell
transduc
retrovir
puromycinselect
vector
encod
murin
ifitm
protein
empti
vector
control
previous
describ
mef
cultur
one
week
puromycin
correct
variat
transduct
effici
gfpencod
retrovirus
pseudotyp
neuraminidas
iav
ha
deriv
influenza
influenza
afpvrostock
envelop
glycoprotein
mlv
lasv
prepar
previous
describ
ifitmexpress
mef
incub
pseudovir
particl
spininocul
minut
cell
wash
return
growth
medium
hour
later
cell
harvest
fix
paraformaldehyd
gfp
express
quantifi
flow
cytometri
cell
cell
incub
vari
concentr
ebiosci
antigenix
america
antigenix
america
sigma
osm
sigma
two
day
later
cell
lyse
lysat
analyz
sdspage
western
blot
goat
antimous
antibodi
r
system
hrpconjug
rabbit
antigoat
igg
secondari
antibodi
sigma
use
detect
express
murin
antibodi
sigma
hrpconjug
rabbit
antimous
igg
secondari
antibodi
santa
cruz
biotechnolog
use
measur
express
tubulin
load
control
express
myctag
murin
ifitm
determin
use
monoclon
antibodi
santa
cruz
biotechnolog
nih
raw
cell
stain
panel
rat
monoclon
antibodi
osm
receptor
clone
mbl
intern
corpor
receptor
clone
r
system
clone
r
system
equal
amount
isotyp
control
antibodi
clone
ebiosci
secondari
label
perform
alexa
donkey
antirat
invitrogen
fluoresc
measur
bd
biosceinc
facscalibur
flow
cytomet
approxim
bp
murin
promot
region
amplifi
wild
type
mef
genom
dna
subclon
xhoi
hindiii
site
luciferas
report
vector
clontech
primer
use
follow
promot
forwardrevers
cac
ata
aaa
ggt
cat
gct
ttt
gaa
gct
gca
ctc
ctt
gct
cca
ttc
gac
tct
gga
aca
atc
tgg
ctg
tag
cac
caa
gag
caa
agg
cag
ctt
tgc
ctg
ctg
tct
cag
cgc
cgt
gtc
ttc
tcc
tgt
ttt
gcc
atc
gtg
ctt
aaa
gga
agc
aag
gag
atg
ggg
ttt
cac
gtt
ttt
gag
gct
gga
aga
nih
cell
cultur
dmem
supplement
calf
serum
colorado
serum
compani
nonessenti
amino
acid
penicillinstreptomycin
cell
well
plate
cotransfect
construct
glucokinas
promoterdriven
constitut
report
transfect
effici
control
cell
transfect
carri
use
transfect
kit
miru
transfect
complex
remov
hour
growth
medium
alon
medium
contain
ngml
murin
ebiosci
antigenix
america
ad
cell
hour
stimul
cell
lyse
enzymat
activ
quantit
mean
commerci
luciferas
assay
system
enzym
activ
kit
promega
plate
reader
perkinelm
untransfect
well
use
determin
background
signal
data
present
background
subtract
luciferas
readout
sampl
normal
backgroundsubtract
readout
sampl
nih
raw
cell
grown
plate
triplic
well
contain
subconflu
cell
incub
growth
medium
alon
treat
hour
medium
contain
ngml
ngml
ngml
osm
cell
ngml
raw
cell
rna
isol
cell
mean
rneasi
mini
kit
qiashredd
column
qiagen
cell
use
control
figur
transfect
high
molecular
weight
poli
c
complex
lyovec
transfect
reagent
invivogen
hour
harvest
primer
probe
sequenc
detect
murin
transcript
follow
aca
atc
aac
atg
cct
forward
primer
cat
ctt
cct
gtc
cct
revers
primer
ctc
ttc
atg
aac
ttc
tgc
tgc
probe
tct
cta
cca
cct
ctg
tgg
forward
primer
atc
cac
tgt
gga
cag
ata
revers
primer
tcc
aca
tct
gcc
ccg
probe
aac
atc
agc
acc
ttg
forward
primer
tgg
tgg
tta
tca
agt
gca
revers
primer
ggt
cct
gaa
gtg
ctt
cac
probe
murin
amplifi
ttc
act
acc
agt
ccc
forward
primer
aga
cct
gtc
agt
tga
revers
primer
caa
cct
tta
agc
atc
aga
ggc
probe
murin
amplifi
aca
tct
atg
cca
ctt
forward
primer
aga
caa
tga
acg
cta
cac
revers
primer
ctc
atg
gct
gtt
tct
ggc
probe
gapdh
see
viral
load
measur
use
housekeep
control
primer
label
fam
includ
ibfq
intern
zen
quencher
dye
integr
dna
technolog
cycl
condit
min
revers
transcript
min
denatur
cycl
second
dentatur
sec
anneal
extens
fluoresc
acquisit
reaction
perform
duplic
mous
lung
inflat
neutral
buffer
formalin
fix
hour
store
phosphatebuff
salin
prior
paraffin
embed
section
deparaffin
subject
heatmedi
epitop
retriev
low
ph
antigen
unmask
solut
vector
lab
section
stain
rabbit
abcam
influenza
viru
goat
abcam
rat
clone
bd
pharmingen
dclamp
rat
clone
imgenex
secondari
fluoresc
label
perform
alexa
fluor
secondari
antisera
donkey
origin
invitrogen
ifitmtranduc
mef
grown
well
chamber
slide
fix
permeabil
immers
mixtur
methanol
aceton
minut
prior
stain
cell
stain
primari
antimyc
clone
santa
cruz
biotechnolog
alexa
fluor
goat
antimous
secondari
antibodi
invitrogen
slide
coverslip
prolong
gold
antifad
mount
medium
contain
dapi
invitrogen
imag
perform
leica
tc
laserscan
confoc
microscop
na
oilimmers
object
brightfield
immunohistochemistri
carri
similar
slide
prepar
primari
antibodi
secondari
label
detect
perform
biotinyl
hors
antirabbit
avidinbiotinperoxidas
complex
nova
red
chromagen
vector
lab
digit
imag
color
balanc
public
